Found 6 matching trials
Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026) PHASE3 The purpose of this clinical study is to evaluate the safety and immunogeni...
Show More Location
Hvidovre Hospital ( Site 0003)
Learn More & Join Trial
Safety, Tolerability, and Immunogenicity of Vaxelis⢠in Children Previously Vaccinated With Vaxelis⢠or Hexyon⢠(V419-016) PHASE4 The primary objectives of this study are to evaluate the safety, tolerabili...
Show More Location
Gemeinschaftspraxis Dres. Adelt, Mettlich-Lambrecht und Denneberg ( Site 0053)
Learn More & Join Trial
A Hepatitis B Vaccine Challenge Study After Previous VaxelisÂŽ Vaccination (V419-013) PHASE3 The purpose of this study is to demonstrate the durability of protection ag...
Show More Location
Tampereen yliopisto Kokkolan rokotetutkimusklinikka ( Site 0009)
Learn More & Join Trial
Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age PHASE3 This study is a Phase 3, randomized, modified double-blind study which aims...
Show More Status
Active Not Recruiting
Location
Kaiser Permanente - Los Angeles Medical Center- Site Number : 8400025
Learn More & Join Trial
Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age PHASE3 This study is a Phase 3, randomized, modified double-blind study which aims...
Show More Status
Active Not Recruiting
Location
Alabama Clinical Therapeutics - Birmingham - St. Vincent's Drive- Site Number : 8400013
Learn More & Join Trial
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008) PHASE3 This study will determine whether participants who receive V419 (PR5I) at 2...
Show More Location
Multiple Locations
Learn More & Join Trial